Patents by Inventor Dan Andersen

Dan Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210161654
    Abstract: A system and method of treating target tissue in a patient's eye, which includes generating a light beam, deflecting the light beam using a scanner to form first and second treatment patterns, delivering the first treatment pattern to the target tissue to form an incision that provides access to an eye chamber of the patient's eye, and delivering the second treatment pattern to the target tissue to form a relaxation incision along or near limbus tissue or along corneal tissue anterior to the limbus tissue of the patient's eye to reduce astigmatism thereof.
    Type: Application
    Filed: February 17, 2021
    Publication date: June 3, 2021
    Inventors: William Culbertson, David Angeley, George R. Marcellino, Dan Andersen
  • Patent number: 10925720
    Abstract: A system and method of treating target tissue in a patient's eye, which includes generating a light beam, deflecting the light beam using a scanner to form first and second treatment patterns, delivering the first treatment pattern to the target tissue to form an incision that provides access to an eye chamber of the patient's eye, and delivering the second treatment pattern to the target tissue to form a relaxation incision along or near limbus tissue or along corneal tissue anterior to the limbus tissue of the patient's eye to reduce astigmatism thereof.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: February 23, 2021
    Assignee: AMO Development, LLC
    Inventors: William Culbertson, David Angeley, George R. Marcellino, Dan Andersen
  • Publication number: 20200390597
    Abstract: A system for ophthalmic surgery includes a laser source configured to deliver an ultraviolet laser beam comprising laser pulses having a wavelength between 320 nm and 370 nm to photodecompose one or more intraocular targets within the eye with chromophore absorbance. The pulse energy, the pulse duration, and the focal spot are such that an irradiance at the focal spot is sufficient to photodecompose the one or more intraocular targets without exceeding a threshold of formation of a plasma and an associated cavitation event. An optical system operatively coupled to the laser source and configured to focus the ultraviolet laser beam to a focal spot and direct the focal spot in a pattern into the one or more intraocular targets. The optical system focuses the laser beam at a numerical aperture that provides for the focal spot to be scanned over a scan range of 6 mm to 10 mm.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 17, 2020
    Inventors: Georg Schuele, Dan Andersen, David Dewey
  • Patent number: 10864114
    Abstract: As shown in the drawings for purposes of illustration, a method and system for making physical modifications to intraocular targets is disclosed. In varying embodiments, the method and system disclosed herein provide many advantages over the current standard of care. Specifically, linear absorption facilitated photodecomposition and linear absorption facilitated plasma generation to modify intraocular tissues and synthetic intraocular lenses.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: December 15, 2020
    Assignee: AMO Development, LLC
    Inventors: Georg Schuele, Dan Andersen
  • Publication number: 20200360131
    Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.
    Type: Application
    Filed: August 4, 2020
    Publication date: November 19, 2020
    Inventors: William Culbertson, Mark S. Blumenkranz, David Angeley, George R. Marcellino, Michael W. Wiltberger, Dan Andersen
  • Patent number: 10758416
    Abstract: A system for ophthalmic surgery includes a laser source configured to deliver an ultraviolet laser beam comprising laser pulses having a wavelength between 320 nm and 370 nm to photodecompose one or more intraocular targets within the eye with chromophore absorbance. The pulse energy, the pulse duration, and the focal spot are such that an irradiance at the focal spot is sufficient to photodecompose the one or more intraocular targets without exceeding a threshold of formation of a plasma and an associated cavitation event. An optical system operatively coupled to the laser source and configured to focus the ultraviolet laser beam to a focal spot and direct the focal spot in a pattern into the one or more intraocular targets. The optical system focuses the laser beam at a numerical aperture that provides for the focal spot to be scanned over a scan range of 6 mm to 10 mm.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: September 1, 2020
    Assignee: AMO Development, LLC
    Inventors: Georg Schuele, Dan Andersen, David Dewey
  • Publication number: 20200138564
    Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.
    Type: Application
    Filed: December 20, 2019
    Publication date: May 7, 2020
    Inventors: William Culbertson, Mark Blumenkranz, David Angeley, George Marcellino, Michael Wiltberger, Dan Andersen
  • Publication number: 20200129287
    Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.
    Type: Application
    Filed: December 23, 2019
    Publication date: April 30, 2020
    Inventors: William Culbertson, Mark Blumenkranz, David Angeley, George Marcellino, Michael Wiltberger, Dan Andersen
  • Publication number: 20200114162
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: September 24, 2019
    Publication date: April 16, 2020
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Greg Stahler, Ananya Mitra, Joyce Huang, Dan Andersen, Alexander K. Arrow, David Moore
  • Patent number: 10617564
    Abstract: A system and method for treating a lesion on target tissue that includes a visualization device for capturing an image of target tissue containing a lesion, a light source for generating a light beam, a scanner for deflecting the light beam in the form of a treatment pattern, and a controller for determining boundaries of the lesion from the captured image, and for controlling the scanner to project the treatment pattern onto the target tissue and within the boundaries of the lesion. An alignment light source can be used to generate an alignment light beam, such that the scanner deflects the alignment light beam in the form of an alignment pattern. The controller controls the scanner to project the alignment pattern onto the target tissue to visually indicate a position of the treatment pattern on the target tissue.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: April 14, 2020
    Assignee: Apple Inc.
    Inventors: Dan Andersen, David Mordaunt
  • Patent number: 10548715
    Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: February 4, 2020
    Assignee: OPTIMEDICA CORPORATION
    Inventors: William Culbertson, Mark Blumenkranz, David Angeley, George Marcellino, Michael Wiltberger, Dan Andersen
  • Patent number: 10548716
    Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: February 4, 2020
    Assignee: OPTIMEDICA CORPORATION
    Inventors: William Culbertson, Mark Blumenkranz, David Angeley, George Marcellino, Michael Wiltberger, Dan Andersen
  • Publication number: 20200009397
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: June 12, 2019
    Publication date: January 9, 2020
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190388700
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: April 12, 2019
    Publication date: December 26, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Scott Delp, Karl Deisseroth, Dan Andersen
  • Patent number: 10512787
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: December 24, 2019
    Assignee: Circuit Therapeutics, Inc.
    Inventors: Scott Delp, Karl Deisseroth, Dan Andersen
  • Patent number: 10478341
    Abstract: A method for cataract surgery on an eye of a patient includes scanning a first focus position of a first pulsed laser beam at a first pulse energy in a first scanning pattern to photodisrupt a tissue structure of a lens with a plurality of pulses of the first laser beam to form one or more cuts within the lens, the cuts being short of reaching a side edge of the lens and being configured to divide the lens into two or more segments which are attached to each other in regions adjacent the side edge of the lens; and afterwards, completely separating the two or more segments of the lens from each other by scanning a second focus position of a second pulsed laser beam having a second pulse energy higher than the first pulse energy in a second scanning pattern that is co-registered to the first scanning pattern.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: November 19, 2019
    Assignee: OPTIMEDICA CORPORATION
    Inventors: Neil Friedman, Barry Seibel, William Culbertson, Georg Schuele, Dan Andersen
  • Patent number: 10405970
    Abstract: A system and method of treating target tissue in a patient's eye, which includes generating a light beam, deflecting the light beam using a scanner to form first and second treatment patterns, delivering the first treatment pattern to the target tissue to form an incision that provides access to an eye chamber of the patient's eye, and delivering the second treatment pattern to the target tissue to form a relaxation incision along or near limbus tissue or along corneal tissue anterior to the limbus tissue of the patient's eye to reduce astigmatism thereof.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: September 10, 2019
    Assignee: OPTIMEDICA CORPORATION
    Inventors: William Culbertson, David Angeley, George R. Marcellino, Dan Andersen
  • Publication number: 20190240500
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitve proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: April 18, 2019
    Publication date: August 8, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190224492
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: April 4, 2019
    Publication date: July 25, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Scott Delp, Karl Deisseroth, Dan Andersen
  • Publication number: 20190217128
    Abstract: One embodiment is directed to an implantable probe system for delivering acoustical energy to a targeted tissue portion of a patient, comprising: a plurality of substrate portions, each substrate portion comprising at least one acoustical emitter; a probe body portion having proximal and distal ends and being movably coupled to the plurality of substrates and configured to at least partially encapsulate the plurality of substrates; and a distal end portion coupled to the distal end of the probe body portion, the distal end portion comprising at least one guiding feature configured to redirect a path of at least one of the substrate portions as such substrate portion is extended through and past the distal end portion by moving the plurality of substrates relative to the probe body portion
    Type: Application
    Filed: January 16, 2019
    Publication date: July 18, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Brian Andrew Ellingwood, Brian Beckey, Christopher L. Towne, Dan Andersen